Wordt geladen...
Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?
Two-thirds of breast tumours are oestrogen-receptor positive and 60–70% of these tumours respond to interventions that reduce the effects of oestrogen. Until recently, tamoxifen was the drug of choice for the treatment of hormone-responsive early and advanced breast cancer. However, tamoxifen is ass...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2410276/ https://ncbi.nlm.nih.gov/pubmed/15150604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601731 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|